Needham & Company Downgrades Cepheid (CPHD) to Hold Following Takeover Sep 6, 2016 09:32AM
ResMed (RMD), St. Jude (STJ), Cepheid (CPHD) Among Med Tech Companies with Most EU Exposure - Needham & Company Jun 24, 2016 09:11AM
Needham & Company Upgrades Cepheid (CPHD) to Buy Dec 17, 2015 06:27AM
Needham & Company Downgrades Cepheid (CPHD) to Hold Oct 21, 2015 07:40AM
Needham & Company Cuts Price Target on Cepheid (CPHD) to $47 Following Pre-Announced 3Q Results Oct 14, 2015 08:12AM


Jul 24, 2015 07:34AM Needham & Company Raises Price Target to $70 on Cepheid (CPHD) Following 2Q15
May 27, 2014 06:13AM Needham & Company Upgrades Cepheid (CPHD) to Buy
Dec 19, 2013 07:20AM Needham & Company Starts Cepheid (CPHD) at Hold
Oct 22, 2010 08:27AM Needham & Company Reiterates a 'Buy' on Cepheid (CPHD); Strong Systems Sales & Biothreat Revs, Guidance Increased
Jul 23, 2010 08:44AM Needham & Company Reiterates a 'Buy' Rating on Cepheid (CPHD); 2Q10 EPS Beat on Higher Gross Margin & Lower R&D
Jul 2, 2010 08:07AM Needham & Company Reiterates a 'Buy' on Cepheid (CPHD); Blood Culture Product Recall Unlikely to Impact MRSA Surveillance Business
Apr 23, 2010 11:03AM Notable Analyst Rating Changes 04/23: YGE, WDC, CPHD, HSY Upgraded; VZ, DO, ASBC, NOK Downgraded
Apr 23, 2010 08:45AM Needham & Company Reiterates a 'Buy' on Cepheid (CPHD); 1Q10 Beat on Strong Test Sales, 2010 Guidance Beatable
Oct 14, 2009 01:52PM Unusual 11 Mid-Day Movers 10/14: CHIO, ACPW, JADE, CNO Higher; CXM, HILL, UCBH, UPI Lower
Oct 14, 2009 08:58AM Needham & Co Upgrades Cepheid (CPHD) to Buy
Jan 9, 2009 09:50AM Needham & Co Downgrades Cepheid (CPHD) to Hold